Secondary prevention of coronary heart disease.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003327:Coronary Disease / Q000628:therapy*; D003920:Diabetes Mellitus / Q000628:therapy; D005247:Feeding Behavior; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy; D006973:Hypertension / Q000628:therapy; D009203:Myocardial Infarction / Q000628:therapy*; D009765:Obesity / Q000628:therapy; D005082:Physical Exertion; D012008:Recurrence; D012306:Risk; D000074606:Smoking Prevention; D013315:Stress, Psychological / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D001241:Aspirin